Dilated cardiomyopathy (DCM) is a condition whereby the normal muscular function of the myocardium is altered by specific or multiple aetiologies. About 25-35% of DCM patients show familial forms of the disease, with most mutations affecting genes encoding cytoskeletal proteins. Most of the DCM-related mutations fall in the Lamin AC gene, in particular in the Coil2B domain of the encoded protein. In this context, we focussed our studies on the crystal structures of two lamin Coil2B domain mutants (R335W and E347K). Both R335 and E347 are higly conserved residues whose substitution has little effects on the Coil2B domain three-dimensional structure; we can thus hypothesize that the mutations may interfere with the binding of components within the nuclear lamina, or of nuclear factors, that have been proposed to interact/associate with lamin A/C.
Introduction
The eukaryotic cell nucleus is a complex membrane-bound organelle that houses and organizes the genome, while providing/supervising its expression. In this context, the lamina, underlying the nuclear membrane, is essential for maintaining nuclear shape, spacing nuclear pore complexes, anchoring and organizing heterochromatin [1] [2] [3] [4] . Lamina is a meshwork of nuclear-specific type V intermediate filaments (IF) called lamins, associated with the nuclear membrane, either directly or through interactions with membrane-bound proteins [2, 3, [5] [6] [7] [8] . As a basic structural unit, lamins form coiled-coil dimers that associate longitudinally to form polar head-to-tail polymers [2, [9] [10] [11] . According to their primary sequence, biochemical properties and expression patterns, lamins have been classified as A-and B-type, which are differentially expressed in cells. The Lamin AC gene (LMNA) maps on the long arm of chromosome 1 (1q21.2-q21.3) and encodes two main isoforms by alternative splicing [16] , Lamin A and C, which are expressed exclusively in differentiated non-proliferating cells [2, 10, 12, 13] .
The translated LMNA protein is a dimer (660 amino acids/ chain) hosting an elongated central a-helical ''rod'' domain, flanked by non-a-helical ''head'' and ''tail'' domains at the Nand C-termini, respectively. Each chain contributes to the rod domain 350 amino acids that host four a-helical segments, named 1A, 1B, 2A and 2B (in sequential order), with heptad-repeat periodicity. The four a-helical segments are interconnected by ''linkers'' termed L1, L12 and L2, which are also held to adopt a-helical conformation [14, 15] . The 1A, 1B, 2A, 2B a-helical segments build the coiled coil rod central domain in the LMNA dimer by associating with the homonymous a-helical segments of the partner chain.
In each LMNA chain, the head domain is about 30 residues and is predicted to be disordered, while the tail domain contains an evolutionary conserved 115-residue globular domain exhibiting an immunoglobulin-like fold [15] [16] [17] . Defects in the LMNA gene have been causally linked to more than 10 different diseases termed laminopathies, with occurrence of cardiac complications which, in most cases, are dilated cardiomyopathy (DCM) [18] [19] [20] [21] . Several laminopathies affect striated muscle (Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, and limb-girdle muscular dystrophy), whereas others primarily disrupt muscle and neurons (Charcot-Marie-Tooth disorder), adipose tissue (autosomal dominant partial lipodystrophy), or adipocytes and bone (mandibuloacral dysplasia) [22] [23] [24] . Dilated cardiomyopathy (DCM) is a myocardial disorder characterized by progressive ventricular dilation and impaired systolic contraction, being a major cause of congestive heart failure worldwide [18, 25] . Here we report the crystal structures of two LMNA Coil2B domain mutants (E347K and R335W) that are discussed at the light of their implications in the context of DCM.
Materials and methods

Cloning and mutagenesis
The Coil2B domain (LMNAcc), comprising residues 303-397, was cloned in pEt151 directional TOPO Expression vector (Invitrogen), as a fusion construct comprising an N-terminal hexa-Histidine affinity tag and a linker (26 residues) containing V5 epitope and TEV Protease recognition site. Mutagenesis to obtain the R335W and E347K mutants was performed on LMNAcc using Pfu-Turbo DNA polymerase (Fermentas), and two synthetic oligonucleotide primers containing the mutations. Following temperature cycling, the products were treated with Dpn I, and sequenced by BMR Sequencing Service, University of Padova, Italy.
Expression and purification
LMNAcc w.t. and mutants were expressed in Escherichia coli strain BL21(DE3) grown in Luria-Bertani medium (Sigma Aldrich), containing 100 mg/ml ampicillin at 37°C until the OD 600 reached 0.8. After cooling the cultures to 25°C, expression of the recombinant protein was induced by the addition of 0.5 mM isopropyl b-D-thiogalactopyranoside (IPTG) and the culture was incubated overnight. After induction, the cells were harvested by centrifugation and resuspended in 100 ml Guanidinium Lysis Buffer (20 mM sodium phosphate pH 7.8, 6 M Guanidine HCl, 500 mM NaCl). The cells were lyzed by sonication and then centrifuged at 23,000g for 1 h at 4°C. The supernatant was loaded on Nickel Sepharose Fast Flow resin (Ge-Healthcare) and eluted by gravity in 20 mM NaH 2 PO 4 pH 4, 8 M urea, 500 mM NaCl. The fusion protein was dialyzed overnight into a refolding buffer (20 mM Tris-HCl pH 8, 150 mM NaCl, 2.4 mM CaCl 2 ). The buffer was subsequently changed to 10 mM Tris-HCl pH 8, 500 mM NaCl using a Sephadex PD10 column. The protein was concentrated to 10 mg/ml using an Amicon Ultra centrifugal filter (Millipore).
Circular dichroism (CD)
Circular dichroism (CD) studies were carried out on a Jasco J810 spectropolarimeter. LMNAcc was soluted in 10 mM Tris-HCl pH 8, 500 mM NaCl (8 M urea was added for the control spectrum). Spectra of a 1 mg/ml protein solution were recorded in a 0.1 cm path length cell and analyzed by means of Jasco J800 software; data were normalized in terms of Mean Residual Ellipticity ( [26] ). Estimates of the secondary structure composition were obtained by means of CDNN version 2.1 (Copyright Ó Gerald Böhm, Institut für Biotechnologie, Martin-Luther Universität Halle-Wittenberg).
Dynamic light scattering (DLS)
The freshly purified proteins were centrifuged at 13,000g for 10 min prior to DLS analysis; all DLS measurements were carried out at 10°C using a DynaPro instrument (Protein Solution, Charlottesville, USA). The DLS data on 10 mg/ml protein solutions resulted to be sufficiently monodisperse (polydispersivity is defined as the standard deviation of the hydrodynamic radius), thus suitable for crystallization experiments [27, 28] .
Crystallization
Crystallization trials on LMNAcc and mutant solutions, concentrated at 10 mg/ml, were performed using an Oryx-8 crystallization robot (Douglas Instruments, East Garston, UK). After two weeks at 20°C no crystals grew, but vitreous spheres were observed under various growth conditions. To overcome the formation of undesired vitreous aggregation, the crystallization trials were incubated at 37°C, at which temperature most of the spheres turned into crystals.
The largest crystals were obtained under the following conditions: 30% 2-methyl-2,4-pentanediol, 0.1 M Hepes pH 7.5, 0.5 M Ammonium Sulfate (LMNAcc), 15% Ethanol, 0.1 M Citrate pH 5.5, 0.2 M Lithium Sulfate (R335W), or 30% 2-methyl-2,4-pentanediol, 0.1 M Sodium Acetate pH 4.6, 0.2 M Sodium Chloride (E347K).
Crystals were cryoprotected in their mother liquors, supplemented with 25% glycerol and flash-frozen in liquid nitrogen. X-ray diffraction data were collected at the European Synchrotron Radiation Facility (Grenoble, France) on beam line ID23-1. Crystals of the w.t. LMNAcc and R335W mutant diffracted both to 3.0 Å, while crystals of the E347K mutant diffracted to 3.6 Å. All crystals are isomorphous and were shown to belong to the hexagonal space group P6 5 22. The diffraction data were processed using the program iMOSFLM [29] and intensities merged using Scala [30] ; data reduction statistics are reported in Table 1 . The crystal structures were solved by molecular replacement using the program MOLREP [31] . The LMNAcc structure (PDB code: 1X8Y [11] ) was used as search model. A single protein molecule was located in the crystal asymmetric unit (statistics for the molecular replacement solutions are listed in Table 1 ). The positioned model molecule was subjected to rigid-body refinement and refined using REFMAC5 [32] . A random set comprising 5% of the data was omitted from refinement for R free calculation. The amino acid sequence of the model was modified to match the mutants correct sequence and fitted to the electron density using the program Coot [33] . A set of final refinement cycles was performed using the program Buster [34] until the R factor and R free values reached the values listed in Table 1 . The stereochemical quality of the model was checked using the program PROCHECK [35] . Atomic coordinates and structure factors for LMNAcc, R335W and E347K mutants have been deposited with the PDB [36] , with accession codes 3V5B, 3V4Q and 3V4W, respectively.
Genetic studies
The 12 exons of the LMNA gene were amplified from peripheral blood-derived genomic DNA by means of polymerase chain reaction (PCR), using primers derived from intronic sequences [37] . The PCR products were analyzed by means of denaturing high-performance liquid chromatography (Transgenomic, San Jose, CA) using the Wave DNA Fragment Analysis System. Heteroduplex fragments were purified (QIAquick Kit, Qiagen, Santa Clarita, CA) and then sequenced using a BigDye-terminator cycle sequencing system (ABI PRISM, Applied Biosystem, Foster City, CA). LMNA gene analysis was performed by direct bidirectional automated sequencing in case of probands with healthy parents, to exclude the rare possibility of recessive forms. The control series for each mutation is composed of 800 normal individuals. Reference sequences used in the study are: LMNA gene: GenBank ID: NC_000001; LMNA mRNA: GenBank ID: NM_170707; Lamin A protein: GenBank ID: NP_733821; LMNC mRNA: GenBank ID: NM 005572; Lamin C protein: GenBank ID: NP005563.
Results and discussion
Production and physical characterization of the proteins
We have cloned three recombinant fragments of human LMNA, which represent the main part of the Coil2B segment (residues 305-397, LMNAcc); these are the wild type LMNAcc, and the two mutants R335W and E347K. The proteins were produced by refolding from denatured inclusion bodies; thus, the proteins were characterized by biophysical analyses in order to verify their correct fold after purification. We performed a circular dichroism (CD) analysis on the LMNAcc sample. The CD spectra highlighted a correctly folded protein composed of 87% a-helical secondary structure, consistent with the LMNAcc structure, which consists of an extended a-helix (Fig. 1) . The remaining 13% of non a-helical structure recorded by the CD spectra is likely due to the His-Tag residues (6 residues) and to the linker between His-Tag and LMNAcc added in the cloning procedure (26 residues). In order to study the stability of the protein, DLS measurements were carried out at different LMNAcc concentrations. The results showed that at 10 mg/ml LMNAcc proved sufficiently monodisperse (19%) to justify crystallization experiments. The results obtained on LMNAcc were used as a guideline for preparation of mutant samples.
Overall structure
We could grow crystals of w.t. LMNAcc and the mutant domains in the hexagonal space group P6 5 22 , with one molecule per asymmetric unit. The protein structure was solved using molecular replacement techniques and refined to 3.0 and 3.6 Å resolution (for LMNAcc/R335W, and for E347K, respectively). The final crystallographic R factor for LMNAcc is 28% and R free is 33%; for R335W R factor is 27.4% and R free is 28.6%; the E347K structure was refined to an R factor value of 32% and R free 34.7% (see Table 1 ). Both w.t. and mutant models comprise amino acids 313-386 (sequence numbers refer to full length LMNA). Superimposition of LMNAcc and its mutants showed that the overall conformation of the molecules is strongly conserved, as expected considering the single residue mutations and crystal isomorphism. Nevertheless, all the three protein structures appear progressively disordered towards the N-terminus. In particular, the first eight N-terminal residues (305-312) and the thirty-six tail residues added in the cloning procedure could not be modelled (while revealing some residual weak electron density). Residues 313-315 exhibit only poor density, which was however sufficient to trace the helix path unambiguously; the rest of the structure exhibits fairly good electron density. The final models display excellent overall stereochemical parameters as reported in Table 1 . The overall structure of the crystallized LMNAcc consists essentially of a single long a-helix (Fig. 2A) . However, around residues 345-355 LMNAcc displays a discontinuity of the heptad-repeat, the so-called ''stutter'', that is an insertion of four extra residues occurring roughly at the center of segment 2B in all IF proteins [38] . The crystallographic analyses revealed that w.t. and mutant LMNAcc display one polypeptide chain per asymmetric unit. However, LMNAcc builds up a parallel coiled coil dimer, as reported for the full length protein, through assembly High resolution shell values in brackets. a R merge = P |I -(I)|/ P I Â 100, where I is intensity of a reflection and (I) is the average intensity.
. c R free is calculated from 5% randomly selected data for crossvalidation. with a symmetry equivalent molecule in the crystal lattice (Fig. 2B) . The dimer is positioned on a crystallographic 2-fold axis, and exhibits a number of intermolecular salt bridges, which stabilize association of the two chains in two main regions at the termini of the domain (residues 313-321 and 369-376). In addition to the canonical coiled coil hydrophobic packing, two main salt bridges are found that probably contribute to the specificity of this interaction. The first occurs between residue Glu342 and the side chain of Lys341 from the opposed chain in the coil. The second salt bridge links Arg331 and Glu330, again of the opposed LMNAcc chain.
Structure of DCM-related mutations in Coil2B domain
Most of the more than 100 mutations related to human DCM fall in the lamin A rod domain [18, 25, 37] . The side chains of Arg335 and Glu347, mutated in this work, are shown by the crystal structures to be exposed at the surface of the coiled coil dimer (Fig. 3) ; nevertheless, the mutations occur at sites that are highly conserved in the known LMNA amino acid sequences [11, 39] . Within the vertebrate IF superfamily, Arg335 is a highly conserved residue, stressing its key role in the correctly folded coil/rod. A mutation to Trp may hamper stability of the coiled-coil, either because of steric hindrance or charge modification. A destabilization of the quaternary assembly, or the achievement of a looser coil, may be at the roots of the pathogenic effect of the R335W mutation, although the substitution of Arg335 with Trp does not perturb the overall conformation of the helix. The second mutated residue, Glu347, is highly conserved through the phyla, except for the invertebrate lamins. The substitution with a positively charged residue, as Lys, might interfere with the formation of an intra-or inter-helical salt bridge, or other forms of polar interaction. Both mutations may alter the interactions of the coiled-coil dimer, and consequently interfere with the lamina assembly; alternatively, they may affect the binding of components within the nuclear lamina, including nuclear factors, that have been proposed to interact/ associate with LMNA [40] [41] [42] [43] .
